Allen Liu

Allen Liu received a B.Sc. degree in Biochemistry (Honors) from the University of British Columbia in 2001. He obtained his Ph.D. in Biophysics in 2007 from the University of California-Berkeley and received his post-doctoral training at The Scripps Research Institute-La Jolla. He started his group in 2012, and he is currently the Associate Chair for Graduate Education and a Professor in Mechanical Engineering, Biomedical Engineering, and Biophysics at the University of Michigan. His current research interests lie in cellular mechanotransduction and bottom-up synthetic biology, and his lab uses tools from quantitative cell biology, synthetic biology, biophysics, and microfluidics. He has received the NIH Director’s New Innovator Award, a Young Innovator by Cellular and Molecular Bioengineering (CMBE), a Rising Star from CMBE-Biomedical Engineering Society (BMES), and was named a Future of Biophysics Burroughs Wellcome Fund Symposium speaker. He is an elected Fellow of the BMES, and a recipient of the Endeavour Executive Fellowship (Australia) and the Alexander von Humboldt Fellowship for Experienced Researcher (Germany)

Synthetic Biology and Engineering Organisms for the Environment

What are engineered microbes? How are they created? And why are scientists developing them? In this lecture, Joff Silberg, Ph.D., Professor of Biosciences at Rice University, will describe what synthetic biology is and how it can be used to develop engineered microbes that have new functions that can identify disease outbreaks, breakdown chemicals, and develop more sustainable fertilizers.

This event is part of the “Engineered Microbes for Environmental Release” webinar series that brings together voices from synthetic biology, ecology, policy, science and technology studies, biotechnology, ethics, and history to explore the social, technological, and environmental dimensions of these innovations. Hosted by the Baker Institute’s Science and Technology Policy Program and co-sponsored by the Rice Synthetic Biology Institute, this webinar series was supported by a grant from Schmidt Sciences and the National Science Foundation (#2223678 & 2515431).

Alejandro Vallejo

I am a biotechnologist and biosecurity specialist with active research and policy engagement at the intersection of synthetic biology, public health, and regulatory governance. My work combines molecular biology, genomics, and bioethics with the development and evaluation of biosafety and biotechnology regulatory frameworks in Latin America and the Caribbean. I have published peer-reviewed research on genomics, molecular diagnostics, and emerging biotechnologies, and I served as a national consultant on biosecurity for international organizations including FAO and PAHO/WHO and National organizations like the Ministry of Environment. My professional focus is on enabling responsible innovation in synthetic biology through evidence-based policy, capacity building, and applied research in resource-limited settings.

Rennos Fragkoudis

Rennos Fragkoudis completed his PhD on molecular virology and viral pathogenesis at the University of Edinburgh and for ~15 years he concentrated his research on the pathogenesis of arthropod-borne viruses (arboviruses) in both vertebrate and invertebrate systems working with alpha-, flavi- and bunyaviruses.
Since November 2019, Rennos is the Head of the Edinburgh Genome Foundry at the University of Edinburgh’s School of Biological Sciences. In this role, he leads a multidisciplinary team focused on advancing high-throughput Engineering Biology through the innovative application of laboratory automation and robotics. Under his leadership, the Edinburgh Genome Foundry has become a hub for automated Engineering Biology, fostering collaboration across academia and industry and working on a large variety of projects addressing grand challenges.

Susan Rosser

Susan is Professor of Synthetic Biology and Royal Academy of Engineering (RAEng) Chair in Emerging Technologies at the University of Edinburgh. She was Director of the UK Centre for Mammalian Synthetic Biology and is currently the director of the newly funded Engineering Biology Mission Hub for Advanced Therapeutics. Prof Rosser is Co-director of the Edinburgh Genome Foundry for synthetic DNA assembly and cell phenotyping. Her research focuses on using engineering biology approaches for developing and controlling genetic circuits for applications in cell and gene therapies as well as metabolic engineering. Prof Rosser is a member of the UK Engineering Biology Advisory Panel. She is also co-founder of two early-stage start-ups using a combination of AI and engineering biology for new gene therapies and enzyme replacement therapies for rare diseases.

Seung Hwan Lee

Seung Hwan “Allen” Lee is an Assistant Professor of Chemical Engineering and Materials Science and Ray D. & Mary T. Johnson/Mayon Plastics Professor at the University of Minnesota, Twin Cities. His passion for engineering microorganisms to enable sustainable energy and chemical production began during his undergraduate research at UCLA under Prof. James Liao. After completing his undergraduate studies, he earned his Ph.D. in Chemical and Biomolecular Engineering from Rice University, where he worked under the guidance of Prof. Ramon Gonzalez. His undergraduate and doctoral research focused on the efficient biological utilization of one-carbon (C1) compounds through engineering native and synthetic metabolic pathways. As one of the co-inventors of the Formyl-CoA Elongation (FORCE) pathways, he helped develop a novel approach for converting C1 feedstock into value-added small molecules. During his postdoc under the guidance of Prof. Greg Stephanopoulos at MIT, he has expanded his research to include engineering non-model organisms, leveraging their inherent abilities to efficiently utilize C1 and C2 feedstocks. Beyond his research, Allen is actively engaged in biotechnology and climate technology communities, participating in organizations such as the Society for Industrial Microbiology and Biotechnology (SIMB), the Engineering Biology Research Consortium (EBRC), and the MIT Energy Conference.

Rodrigo Ledesma-Amaro

Rodrigo Ledesma-Amaro is a Professor at Imperial College London, where he leads a research group working on Engineering Biology and sustainability. He is the director of the Bezos Centre for Sustainable Proteins and the Microbial Food Hub. His research focuses on the use of microorganisms to convert renewable feedstocks into valuable products (such as food ingredients). He has published over 200 articles, most on topics related to microbial bioproduction (precision, biomass and traditional fermentation).
Rodrigo obtained his PhD at the University of Salamanca (Spain). Before joining Imperial, he carried out his postdoctoral research at the National Research Institute for Agriculture, Food and the Environment (INRAE, France). He has been a visiting researcher at Chalmers University of Technology (Sweden) and AIST (Japan).

Joshua Wentzel

Josh Wentzel is the Assistant Director of the Biosecurity and Pandemic Policy Center, part of the Scowcroft Institute for International Affairs at the Texas A&M Bush School of Government & Public Service.​ Based at the Bush School DC, Josh has six years of experience working in Congress, where he spent time in both chambers, working in the House and on the Senate Committee on Health, Education, Labor and Pensions (HELP) working on pandemic preparedness, stockpiling, and biosecurity issues. During the COVID-19 pandemic response, Josh joined the U.S. Department of Health and Human Services, working closely with the Assistant Secretary for Preparedness and Response (ASPR) on distribution of COVID-19 medical countermeasures, daily situational awareness reports, and ASPR testimony to Congress and communication with State and Local governments. He holds a BA in International Studies from Emory University and an MS in Biohazardous Threat Agents and Emerging Infectious Diseases from Georgetown University.

Mark Bathe

Mark Bathe is a Professor in the Department of Biological Engineering at MIT, a Member of the Harvard Medical School Initiative for RNA Medicine, and an Associate Member of the Broad Institute of MIT & Harvard. He obtained his Doctoral Degree at MIT working in the Departments of Biological, Chemical, and Mechanical Engineering before moving to the University of Munich for his postdoctoral research in Biological Physics. He returned to MIT in 2009 to join the faculty in the Department of Biological Engineering, where he runs an interdisciplinary research group focused on engineering nucleic acids for the targeted delivery of therapeutics and vaccines, phenotypic profiling of neuronal circuits, and molecular computing and data storage. He is academic co-founder of Cache DNA and Kano Therapeutics, and in his free time he enjoys running, biking, swimming, and skiing, amongst other outdoor activities.

Xu Zhang

Dr. Zhang’s work integrates genetic engineering, electrochemistry, and device design to develop living microbial systems for bioelectronics and functional biomaterials.

Christian Euler

I am a metabolic engineer and systems biologist with research interests primarily focused on finding/developing novel biological pathways for waste upcycling. My group does “full stack” metabolic engineering, from in silico modelling and design through to bench-scale fermentation to evaluate scalability. I am also the co-founder of Phycus Biotechnologies, which makes bio-based glycolic acid using a novel, sustainable fermentation process.

NextGen Omics, Spatial & Data UK 2025

The NextGen Omics, Spatial & Data UK event, now in its 18th year, unites the multi-omics, spatial biology, and data science communities. Held annually in London, it serves as a key meeting point for influential researchers, healthcare leaders, and technology innovators from the UK and Europe. The event aims to address the complexity of interpreting and integrating multi-omics data by fostering dialogue, sharing best practices, and inspiring cross-sector collaboration among teams from academia, pharma, and biotech, ultimately aiming to accelerate the development of life-saving treatments for patients.

Alberto Donayre

Dr. Alberto J. Donayre-Torres is a Professor in the Department of Bioengineering at Universidad de Ingeniería y Tecnología (UTEC) in Lima, Peru. He holds a Ph.D. in Plant Genetics and Biotechnology from CINVESTAV-IPN, Mexico (2009), and completed postdoctoral training at the National Autonomous University of Mexico (UNAM) and Colorado State University (USA), where he spent five years advancing synthetic biology platforms for programmable biological systems. His research sits at the convergence of synthetic biology, advancing biomaterials using bioconjugation engineering (ACS Omega, 2025). He leads projects developing open-source tools for DNA assembly (pyBrick-DNA, J. Comp. Biol., 2023) and develops international collaboration on predictive biomaterial modeling AI-assisted. Dr. Donayre has supervised undergraduate and graduate research in recombinant protein synthesis, hydrogel functionalization, and bioconjugation — and actively contributes to the global synthetic biology community as co-organizer of international congresses and developer of open bioengineering platforms.

Joy Y. Zhang

Joy Y. Zhang is a Professor of Sociology and Founding Director of the Centre for Global Science and Epistemic Justice (GSEJ) at the University of Kent. Her research examines evolving science–society dynamics and their implications for the global ethical governance of emerging life sciences. Conceptually, her work advances the theorisation of cosmopolitanisation, decolonisation, commoning, epistemic justice, and subaltern politics. Empirically, her research focuses on four major scientific powers—China, India, the UK, and the US. She has studied the governance and science diplomacy of emerging life sciences—including stem cells, synthetic biology, genome editing, and experimental therapies—alongside climate politics, food movements, and environmental engineering. She currently leads three cutting-edge social research programmes on engineering biology and its applications in critical minerals, biomedicine, and agriculture, with the aim of informing social and policy deliberation in the UK and internationally. She is the author of three academic books and publishes widely in high-impact journals across the natural and social sciences. She is frequently interviewed by global media and advises leading research and policy institutions in Europe and Asia.

Delaney Beckner

Arjun Khakhar

My group focuses on using synthetic control systems to re-engineer plants, filamentous fungi, and viruses. I am passionate about fighting global hunger and malnutrition. My major hobbies are cooking, making art, and reading. Science fiction is my favorite genre and I love that my job gives me the opportunity to bring some of the things I have read about closer to reality.

Biomarkers and Precision Medicine US 2025

Biomarkers & Precision Medicine US takes place on October 27 – 28 in San Francisco, CA. Running across two full days, with 15 tracks across three dedicated programmes it’s the must attend event for those involved in bringing next-generation personalized treatments to market.

In 2025, the event will feature three core programs:

  • Biomarkers – Focusing on the discovery, validation, and application of biomarkers and diagnostics in personalized healthcare.
  • Spatial Biology for Precision Medicine – Highlighting the importance of spatial insights in the development of precision therapies.
  • Digital Pathology & AI – Exploring the integration of digital pathology and artificial intelligence in transforming clinical diagnostics.

The Biomarkers, Spatial Biology for Precision Medicine, and Digital Pathology programmes come together to create a must attend event. The programme offers opportunities to showcase the latest innovations, meet and collaborate with over 1000 senior biomarker and precision medicine scientists from the pharma and biotech industry.

Register now and book your complemetary place at the event- it includes access to over 100 presentations, opportunities to network with 80+ exhibitors, refreshments and drinks reception.

Yousong Ding

Dr. Yousong Ding received his B.S. in Applied Chemistry from Peking University in 2000, his M.S. in Chemistry (Advisor: Prof. Liangcheng Du) from the University of Nebraska–Lincoln in 2004, and his Ph.D. in Medicinal Chemistry from the University of Michigan–Ann Arbor in 2010, where he trained under Professor David Sherman. He subsequently completed postdoctoral research with Professor Frances Arnold at Caltech. In 2012, Dr. Ding returned to Michigan to join Pfizer Inc. (Kalamazoo, MI) before beginning his independent academic career at the University of Florida in July 2013. He is currently a Professor of Medicinal Chemistry at UF. Dr. Ding’s research group integrates synthetic biology, medicinal chemistry, microbiology, molecular biology, and microbiome engineering to discover and develop bioactive natural products that address current and emerging medical challenges. At UF, he has published over 60 peer-reviewed papers and filed more than 20 invention disclosures. He is also a frequent reviewer for funding agencies including the NIH, NSF, and others.

Catherine McCarthy

Catherine McCarthy serves as the Director of the National Informal STEM Education Network (NISE Network) and is Project Manager Senior for the Arizona State University Center for Innovation in Informal STEM Learning (CIISL) in the School for the Future of Innovation in Society. McCarthy has more than twenty years of experience developing, implementing, and studying STEM learning and public engagement on a variety of science and technology topics. The National Informal STEM Education Network (NISE Network) is a community of informal educators and scientists dedicated to supporting learning about science, technology, engineering, and math (STEM) across the United States.

Cresten Mansfeldt

Cresten B. Mansfeldt is an Assistant Professor of Environmental Engineering at the University of Colorado Boulder, where he leads research at the intersection of synthetic biology, environmental microbiology, and wastewater surveillance and management. His work focuses on tracking and mitigating emerging contaminants, including synthetic biology products, within urban water systems. Prof. Mansfeldt has published extensively on microbial ecology, biotechnological risk, and post-fire water impacts, and actively bridges academic, regulatory, and community sectors to advance environmental resilience.